ScholarLens Back to search
2008•Journal of medical imagingRequires access

The combined modality treatment of upper gastrointestinal hemorrhage and/or portal hypertension in patients with liver cirrhosis

GE Lian-gang

Open publisher page 0 citations

Abstract

Objective:To explore the better therapeutic method in treating upper gastrointestinal hemorrhage for portal hypertension in liver cirrhosis.Methods:109 patients, who underwent percutaneous transhepatic variceal embolization (PTVE) plus partial splenic embolization (PSE) from 1990 to 2006, were retrospectively analyzed in this study. All these enrolled patients were firstly subjected to PTVE and, if effective, received PSE subsequently,with a median follow-up of at least one year.Results:Of the 109 patients, 96 had no reoccurrence of hemorrhage within 1 years, in which 78 were under the efficiently control of hemorrhage as well as hypersplenism within 3 years.Conclusion:Currently, this combined modality therapy is the best clinical choice for the treatment of such severe complications in patients with liver cirrhosis.

About this research paper

What this paper is about

Objective:To explore the better therapeutic method in treating upper gastrointestinal hemorrhage for portal hypertension in liver cirrhosis.Methods:109 patients, who underwent percutaneous transhepatic variceal embolization (PTVE) plus partial splenic embolization (PSE) from 1990 to 2006, were retrospectively analyzed in this study. All these enrolled patients were firstly subjected to PTVE and, if effective, received PSE subsequently,with a median follow-up of at least one year.Results:Of the 109 patients, 96 had no reoccurrence of hemorrhage within 1 years, in which 78 were under the efficiently control of hemorrhage as well as hypersplenism within 3 years.Conclusion:Currently, this combined modality therapy is the best clinical choice for the treatment of such severe complications in patients with liver cirrhosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the better therapeutic method in treating upper gastrointestinal hemorrhage for portal hypertension in liver cirrhosis.Methods:109 patients, who underwent percutaneous transhepatic variceal embolization (PTVE) plus partial splenic embolization (PSE) from 1990 to 2006, were retrospectively analyzed in this study. All these enrolled patients were firstly subjected to PTVE and, if effective, received PSE subsequently,with a median follow-up of at least one year.Results:Of the 109 patients, 96 had no reoccurrence of hemorrhage within 1 years, in which 78 were under the efficiently control of hemorrhage as well as hypersplenism within 3 years.Conclusion:Currently, this combined modality therapy is the best clinical choice for the treatment of such severe complications in patients with liver cirrhosis.

Key concepts: Medicine, Cirrhosis, Portal hypertension, Percutaneous, Embolization, Radiology, Surgery, Internal medicine

Back to paper searchBrowse research topicsOriginal source
The combined modality treatment of upper gastrointestinal hemorrhage and/or portal hypertension in patients with liver cirrhosis — Research Paper | ScholarLens